Asia

Teva, Handok to establish business venture in Korean pharma market

Monday, December 17, 2012 01:41 PM

Teva Pharmaceutical Industries, an Israel-based pharmaceutical company, and Handok Pharmaceuticals, a pharmaceutical/healthcare company in Korea, have agreed to establish a business venture in South Korea, allowing Teva to gain entrance into the Korean pharmaceutical market, currently valued at approximately $14 billion.

More... »

Perceptive Informatics opens first customer care office in China

Monday, December 10, 2012 10:46 AM

Perceptive Informatics, an e-Clinical solutions provider and subsidiary of PAREXEL International, has opened a customer care office in Shanghai to service biopharmaceutical researchers in China and Taiwan who are using Perceptive’s technology solutions.

More... »

Covance receives SFDA GLP certification for early development facility

Wednesday, December 5, 2012 09:16 AM

Covance, a drug development services company, announced that its early development facility located in Shanghai, China, has received a Good Laboratory Practice (GLP) certificate from the State Food and Drug Administration (SFDA) of the People’s Republic of China.

More... »

PAREXEL, NTUH to support clinical research in Taiwan

Monday, December 3, 2012 12:17 PM

PAREXEL International, a global biopharmaceutical services provider, and the National Taiwan University Hospital (NTUH) have established a collaboration to provide drug development services in Taiwan.

More... »

TauRx receives $111.8M from Genting for Alzheimer's trials

Tuesday, November 20, 2012 02:02 PM

TauRx Pharmaceuticals of Singapore has received a further equity investment of $31.5 million from Genting Management (GMS), a Singapore-based subsidiary of Genting Berhad.

More... »

NeuroVive, Sihuan Pharma collaborate on CicloMulsion and NeuroSTAT in China

Tuesday, November 20, 2012 10:25 AM

NeuroVive, a mitochondrial medicine company based in Sweden, has signed a collaboration agreement with Sihuan Pharmaceutical Holdings Group, based in China, for the development and commercialization of NeuroVive's most clinically advanced products CicloMulsion and NeuroSTAT in China.

More... »

Novartis to build $500M biotech facility in Singapore

Wednesday, October 31, 2012 01:38 PM

Novartis has decided to construct a new state-of-the-art biotechnology production site in Singapore with an investment valued at over $500 million.

More... »

AstraZeneca, Ironwood announce linaclotide collaboration for China

Friday, October 26, 2012 02:20 PM

AstraZeneca, a global biopharmaceutical company, and Ironwood Pharmaceuticals, a Cambridge, Mass.-based entrepreneurial pharmaceutical company, have signed an agreement to co-develop and co-commercialize Ironwood’s linaclotide in China.

More... »

WuXi AppTec opens first cGMP biologics facility in China

Monday, October 22, 2012 11:11 AM

WuXi AppTec, a pharmaceutical, biotechnology and medical device R&D outsourcing company, has opened a cGMP biologics facility in China.

More... »

Takeda, Advinus initiated multi-year drugs discovery collaboration

Thursday, October 4, 2012 02:19 PM

Takeda Pharmaceutical, a Japanese research-based pharmaceutical company, and Advinus Therapeutics, a privately held research-based pharmaceutical company based in India, have entered into an agreement to initiate a three-year discovery collaboration focused on novel targets for major therapeutic areas, including inflammation, CNS and metabolic diseases.

More... »